Nicola Beltraminelli
Corporate Officer/Principal at INNATE PHARMA
Net worth: 25 395 $ as of 2024-05-30
Profile
Nicola Beltraminelli is currently the Director at Mabdesign Association and the Chief Development Officer & Vice President at Innate Pharma SA. Previously, he worked as the Chief Technical Officer at Lysogene SA. He holds a doctorate degree from the University of Lausanne.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
INNATE PHARMA SA CLASS A
0.01% | 2023-12-30 | 9,246 ( 0.01% ) | 25 395 $ | 2024-05-30 |
Nicola Beltraminelli active positions
Companies | Position | Start |
---|---|---|
INNATE PHARMA | Corporate Officer/Principal | 2021-12-31 |
Mabdesign Association
Mabdesign Association Miscellaneous Commercial ServicesCommercial Services MabDesign Association is a French biotherapy industry association that aims to structure the biopharmaceutical industry from its R&D phases to biomanufacturing and marketing. The private company is based in Lyon, France and was founded in 2014. The association offers services to help companies strengthen their competitiveness and implement a solid intellectual property strategy. MabDesign's board of directors is composed of a pharmaceutical industry college and a competitiveness cluster college. The CEO is Nicolas Groux. | Director/Board Member | - |
Former positions of Nicola Beltraminelli
Companies | Position | End |
---|---|---|
LYSOGENE | Chief Tech/Sci/R&D Officer | - |
Training of Nicola Beltraminelli
University of Lausanne | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
INNATE PHARMA | Health Technology |
LYSOGENE | Commercial Services |
Private companies | 1 |
---|---|
Mabdesign Association
Mabdesign Association Miscellaneous Commercial ServicesCommercial Services MabDesign Association is a French biotherapy industry association that aims to structure the biopharmaceutical industry from its R&D phases to biomanufacturing and marketing. The private company is based in Lyon, France and was founded in 2014. The association offers services to help companies strengthen their competitiveness and implement a solid intellectual property strategy. MabDesign's board of directors is composed of a pharmaceutical industry college and a competitiveness cluster college. The CEO is Nicolas Groux. | Commercial Services |
- Stock Market
- Insiders
- Nicola Beltraminelli